15:45 EDT Catalyst Pharmaceuticals trading resumes
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CPRX:
- Catalyst Pharmaceuticals Reports FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy Granted to Santhera Pharmaceuticals
- Catalyst Pharmaceuticals trading halted, news pending
- Catalyst Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 8, 2023
- Catalyst Pharmaceuticals appoints Daly as Chief Executive Officer
- Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer